ZA919938B - Short peptides with insulin activity - Google Patents

Short peptides with insulin activity

Info

Publication number
ZA919938B
ZA919938B ZA919938A ZA919938A ZA919938B ZA 919938 B ZA919938 B ZA 919938B ZA 919938 A ZA919938 A ZA 919938A ZA 919938 A ZA919938 A ZA 919938A ZA 919938 B ZA919938 B ZA 919938B
Authority
ZA
South Africa
Prior art keywords
amino acid
short peptides
covalent bond
insulin activity
formula
Prior art date
Application number
ZA919938A
Other languages
English (en)
Inventor
Stefan Mullner
Mullner Stefan
Wolfgang Koenig
Koenig Wolfgang
Guenter Mueller
Mueller Guenter
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ZA919938B publication Critical patent/ZA919938B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA919938A 1990-12-19 1991-12-18 Short peptides with insulin activity ZA919938B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4040574 1990-12-19

Publications (1)

Publication Number Publication Date
ZA919938B true ZA919938B (en) 1992-09-30

Family

ID=6420676

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA919938A ZA919938B (en) 1990-12-19 1991-12-18 Short peptides with insulin activity

Country Status (24)

Country Link
US (1) US5461035A (xx)
EP (1) EP0491361B1 (xx)
JP (2) JP3378588B2 (xx)
KR (1) KR100237948B1 (xx)
AT (1) ATE177753T1 (xx)
AU (1) AU643349B2 (xx)
CA (1) CA2058020C (xx)
CZ (1) CZ284568B6 (xx)
DE (1) DE59109109D1 (xx)
DK (1) DK0491361T3 (xx)
ES (1) ES2130130T3 (xx)
FI (1) FI105816B (xx)
GR (1) GR3030510T3 (xx)
HR (1) HRP940839B1 (xx)
HU (1) HU222493B1 (xx)
IE (1) IE914408A1 (xx)
IL (1) IL100400A (xx)
NO (1) NO308951B1 (xx)
NZ (1) NZ241029A (xx)
PT (1) PT99850B (xx)
SK (2) SK282361B6 (xx)
TW (1) TW227004B (xx)
YU (1) YU189891A (xx)
ZA (1) ZA919938B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2137937T3 (es) * 1991-11-29 2000-01-01 Hoechst Ag Peptidos con efecto del tipo de insulina.
SE0002716L (sv) * 2000-07-18 2002-01-19 Lars Wahlberg Komposition mot insekter
CN100354118C (zh) * 2001-01-15 2007-12-12 米其林技术公司 轮胎成型鼓
US7833513B2 (en) 2004-12-03 2010-11-16 Rhode Island Hospital Treatment of Alzheimer's Disease
KR101909052B1 (ko) 2017-02-09 2018-10-17 강원대학교산학협력단 인슐린의 a 사슬로부터 유래된 펩타이드 단편 및 이를 포함하는 당뇨병 또는 당뇨병성 창상의 예방 또는 치료용 약학 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2740406A1 (de) * 1977-09-08 1979-03-22 Hoechst Ag Teilgeschuetzte human-insulin-a-kette und verfahren zu ihrer herstellung
DE2801175A1 (de) * 1978-01-12 1979-07-19 Hoechst Ag Verfahren zur herstellung cysteinhaltiger peptide
DD147942A1 (de) * 1979-08-20 1981-04-29 Guenter Losse Verfahren zur herstellung von cystin-peptiden mit insulinaehnlicher wirkung
FR2525592B1 (xx) * 1982-04-26 1984-09-14 Pasteur Institut

Also Published As

Publication number Publication date
EP0491361A3 (en) 1993-11-24
ATE177753T1 (de) 1999-04-15
KR920012115A (ko) 1992-07-25
HU914009D0 (en) 1992-03-30
AU643349B2 (en) 1993-11-11
US5461035A (en) 1995-10-24
CA2058020C (en) 2003-10-28
NO914999L (no) 1992-06-22
EP0491361B1 (de) 1999-03-17
JP3378588B2 (ja) 2003-02-17
IL100400A0 (en) 1992-09-06
NO914999D0 (no) 1991-12-18
AU8982591A (en) 1992-06-25
PT99850B (pt) 1999-06-30
DE59109109D1 (de) 1999-04-22
SK282360B6 (sk) 2002-01-07
IL100400A (en) 1998-01-04
CA2058020A1 (en) 1992-06-20
HRP940839B1 (en) 2000-02-29
FI915933A (fi) 1992-06-20
HRP940839A2 (en) 1997-06-30
SK282361B6 (sk) 2002-01-07
CS387991A3 (en) 1992-07-15
FI915933A0 (fi) 1991-12-17
NO308951B1 (no) 2000-11-20
PT99850A (pt) 1992-11-30
ES2130130T3 (es) 1999-07-01
JP2003176237A (ja) 2003-06-24
IE914408A1 (en) 1992-07-01
NZ241029A (en) 1993-01-27
KR100237948B1 (ko) 2000-01-15
JPH04295496A (ja) 1992-10-20
HUT59697A (en) 1992-06-29
JP3802863B2 (ja) 2006-07-26
GR3030510T3 (en) 1999-10-29
FI105816B (fi) 2000-10-13
HU222493B1 (hu) 2003-07-28
TW227004B (xx) 1994-07-21
DK0491361T3 (da) 1999-10-11
YU189891A (sh) 1995-10-03
EP0491361A2 (de) 1992-06-24
CZ284568B6 (cs) 1999-01-13

Similar Documents

Publication Publication Date Title
HU902697D0 (en) Process for the enzymatic removal of the n-terminal sequence of proteins
AU1563588A (en) Pasteurizable, freeze-driable hemoglobin-based blood substitute
DE3772521D1 (de) Insulinzubereitung fuer nicht-parenterale verabreichung.
GR3030703T3 (en) Process for the production of biologically active protein (e.g. TGF)
DK0790255T3 (da) Monoklonale antistoffer som er rettet mod den cytotoksiske lymfocytmodningsfaktor
HK1002901A1 (en) A composition used as a therapeutic agent against chronic viral hepatic diseases
EP0532915A3 (en) Phosphoinositolglycan-peptide with insulin like activity
ATE130312T1 (de) Polypeptid mit sich wiederholenden zelladhäsiven hauptsequenzen.
FI892185A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten peptidiyhdisteiden valmistamiseksi
ZA919938B (en) Short peptides with insulin activity
AU2002307510A1 (en) Cytokine protein family
HUT50195A (en) New peptites hindering the activity of immune system and medical compositions containing them and process for production of these peptides and compositions
AU6860294A (en) New chondrocyte proteins
JPS5775960A (en) Purified polypeptide
ATE124264T1 (de) Verwendung eines polypeptids mit humaner interleukin-2 aktivität zur herstellung pharmazeutischer zusammensetzungen zur behandlung von pneumothoraxen.